CFM Wealth Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
CFM Wealth Partners's RGEN Position: Q1 2022 in Review
CFM Wealth Partners sold out of Repligen (RGEN) in Q1 2022, closing a stake of 1,000 shares — an estimated $258K sold.
CFM Wealth Partners first reported a position in RGEN in Q4 2019 and held it in 7 quarters. The position peaked at $428K in Q3 2020. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.
- CFM Wealth Partners reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
- CFM Wealth Partners sold 1,000 Repligen shares in Q1 2022, an estimated $258K.
- CFM Wealth Partners first reported a position in Repligen in Q4 2019 and held it in 7 quarters.
- CFM Wealth Partners's Repligen position peaked at $428K in Q3 2020.
- 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.
Based on CFM Wealth Partners's 13F filing for Q1 2022, filed 14 Apr 2022.